53mon MSN
Sarepta’s stock plummets as disappointing trial data raise questions on DMD drug’s success
Monday after the biotechnology company disclosed disappointing drug-trial data, which could lengthen the timeline of the ...
A personal reflection on food insecurity and digital empathy—how Instagram and other social media transform scarcity into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback